Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  1. Pubblicazioni

Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment

Articolo
Data di Pubblicazione:
1994
Citazione:
Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment / Boiardi, L; Macchioni, P; Salvarani, Carlo; Rossi, F; Casadei Maldini, M; Mancini, R; Beltrandi, E; Portioli, I.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 12:(1994), pp. 357-362.
Abstract:
38 untreated patients suffering from rheumatoid arthritis (RA) were studied to evaluate the relationship between serum sIL-2R levels and laboratory and clinical indexes of disease activity and circulating lymphocyte subpopulations. Furthermore, we serially analyzed the correlation between the clinical response to oral gold (Auranofin) treatment and serum sIL-2R levels in 28 RA patients.
Tipologia CRIS:
Articolo su rivista
Keywords:
Administration, Oral; Aged; Arthritis, Rheumatoid; Auranofin; Female; Humans; Male; Middle Aged; Prospective Studies; Receptors, Interleukin-2
Elenco autori:
Boiardi, L; Macchioni, P; Salvarani, Carlo; Rossi, F; Casadei Maldini, M; Mancini, R; Beltrandi, E; Portioli, I.
Autori di Ateneo:
SALVARANI CARLO
Link alla scheda completa:
https://iris.unimore.it/handle/11380/1082997
Pubblicato in:
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0